The Molecular Genetics of von Willebrand Disease

The Molecular Genetics of von Willebrand Disease

Quantitative and/or qualitative deficiency of von Willebrand factor (vWF) is associated with the most common inherited bleeding disease von Willebrand disease (vWD). vWD is a complex disease with clinical and genetic heterogeneity. Incomplete penetrance and variable expression due to genetic and env...

Full description

Bibliographic Details
Main Author:	Ergül Berber
Format:	Article
Language:	English
Published:	Galenos Publishing House 2012-12-01
Series:	Turkish Journal of Hematology
Subjects:	von willebrand factor von willebrand disease von willebrand factor biosynthesis
Online Access:	https://jag.journalagent.com/z4/download_fulltext.asp?pdir=tjh&un=TJH-39205

Similar Items

Von Willebrand Factor Multimeric Assay in Acquired von Willebrand Disease Diagnosis: A Report of Experience from North Estonia Medical Centre
by: Marika Pikta, et al.
Published: (2021-06-01)

Patient with von Willebrand Disease for Gynaecologic Surgery - Perianaesthetic Concerns
by: Rakesh Garg, et al.
Published: (2008-01-01)

Recombinant von Willebrand Factor for Pediatric Patient with von Willebrand Disease: First Report in Korea
by: Seoin Kim, et al.
Published: (2021-04-01)

Enfermedad de von Willebrand adquirida. Aspectos generales Acquired von Willebrand’s disease. General aspects
by: Alina Díaz Concepción
Published: (2004-04-01)

von Willebrand Disease: The diagnosis and management of this bleeding disorder
by: Basim A. Abd, et al.
Published: (2020-01-01)

Polymorphism in the promoter region of von Willebrand factor gene and von Willebrand disease type 1
by: Daniel Simon, et al.
Published: (2003-12-01)

Genetic Variation in the von Willebrand Factor Gene in Swedish von Willebrand Disease Patients
by: Eric Manderstedt, et al.
Published: (2018-01-01)

Multiple Sclerosis Diagnosed in a Woman With Von-Willebrand Disease: A Case Report
by: Mohsen Farjoud Kouhanjani, et al.
Published: (2022-07-01)

Analysis of von Willebrand Disease in the “Heart of Europe”
by: Inge Vangenechten, et al.
Published: (2022-10-01)

Desmopressin testing in von Willebrand disease: Lowering the burden
by: Jessica M. Heijdra, et al.
Published: (2022-08-01)

Von Willebrand's disease: case report and review of literature
by: Hanae Echahdi, et al.
Published: (2017-06-01)

[Cost-minimization analysis of replacement therapy in the treatment of von Willebrand disease]
by: Giancarlo Castaman
Published: (2016-06-01)

Evaluation of a new semi-automated Hydragel 11 von Willebrand factor multimers assay kit for routine use
by: Pikta Marika, et al.
Published: (2021-01-01)

Structure and Function of Recombinant versus Plasma-Derived von Willebrand Factor and Impact on Multimer Pharmacokinetics in von Willebrand Disease
by: Gritsch H, et al.
Published: (2022-11-01)

Multimer Analysis of Von Willebrand Factor in Von Willebrand Disease with a Hydrasys Semi-Automatic Analyzer—Single-Center Experience
by: Ingrid Skornova, et al.
Published: (2021-11-01)

Common and Rare Variants in Genes Associated with von Willebrand Factor Level Variation: No Accumulation of Rare Variants in Swedish von Willebrand Disease Patients
by: Eric Manderstedt, et al.
Published: (2020-10-01)

Genetic Alterations, DNA Methylation, Alloantibodies and Phenotypic Heterogeneity in Type III von Willebrand Disease
by: Muhammad Asif Naveed, et al.
Published: (2022-05-01)

Von Willebrand disease : basic and clinical aspects /
by: Federici, Augusto B. 534507
Published: (c201)

Active von Willebrand Factor in patients with a bleeding diathesis
by: Lisa N. van der Vorm, et al.
Published: (2020-12-01)

The Importance and Complications of Sequencing of Von Willebrand Gene in Von Willebrand Disease
by: Zolkova J, et al.
Published: (2019-04-01)

Real-World Data on the Effectiveness and Safety of wilate for the Treatment of von Willebrand Disease
by: Michelle Sholzberg, et al.
Published: (2021-07-01)

Diagnosis of von Willebrand disease during the management of deep neck abscess: A case report
by: Akihisa Tanaka, et al.
Published: (2022-12-01)

VON WILLEBRAND DISEASE
by: Valeriu Popescu, et al.
Published: (2009-11-01)

Establishing reference intervals for von Willebrand factor multimers
by: Pikta Marika, et al.
Published: (2022-01-01)

Von Willebrand Disease in the elderly: clinical perspectives
by: Chapin J
Published: (2018-08-01)

Polyphosphate Activates von Willebrand Factor Interaction with Glycoprotein Ib in the Absence of Factor VIII In Vitro
by: Marcela Montilla, et al.
Published: (2022-11-01)

Quantitative 3D microscopy highlights altered von Willebrand factor α‐granule storage in patients with von Willebrand disease with distinct pathogenic mechanisms
by: Maurice Swinkels, et al.
Published: (2021-08-01)

Human von Willebrand factor/factor VIII concentrates in the management of pediatric patients with von Willebrand disease/hemophilia A
by: Castaman G, et al.
Published: (2016-06-01)

Von Willebrand hastalığı’nda oral cerrahi yaklaşım: olgu sunumu
by: Ahmet Arslan, et al.
Published: (2011-11-01)

Allopurinol-induced acquired von Willebrand syndrome
by: Juan Eirís, et al.
Published: (2023-10-01)

Acquired von Willebrand Syndrome in Patients With Ventricular Assist Device
by: Antoine Rauch, et al.
Published: (2019-02-01)

Obstacles to Early Diagnosis and Treatment of Inherited von Willebrand Disease: Current Perspectives
by: Castaman G, et al.
Published: (2021-03-01)

Hemostatic potential of recombinant von Willebrand factor and standard or pegylated extended half-life recombinant factor VIII on thrombus formation under high shear flow
by: Hiroaki Yaoi, et al.
Published: (2023-12-01)

The effect of recombinant versus plasma-derived von Willebrand factor on prolonged PFA closure times in ECMO patients with acquired von Willebrand syndrome – an observational study
by: Martin Büchsel, et al.
Published: (2023-01-01)

Identification of von Willebrand factor D4 domain mutations in patients of Afro‐Caribbean descent: In vitro characterization
by: Marie‐Daniéla Dubois, et al.
Published: (2022-05-01)

PROTEOLYTIC PROCESSING OF VON WILLEBRAND FACTOR BY ADAMTS13 AND LEUKOCYTE PROTEASES
by: Stefano Lancellotti, et al.
Published: (2013-09-01)

Effects of Plasmin on von Willebrand Factor and Platelets: A Narrative Review
by: Lisa N. van der Vorm, et al.
Published: (2018-04-01)

Acquired von Willebrand disease: from theory to practice. A single center experience - three case reports
by: Colită Andrei, et al.
Published: (2016-03-01)

Ristocetin dependent cofactor activity in von Willebrand disease diagnosis: Limitations of relying on a single measure
by: Pamela A. Christopherson, et al.
Published: (2022-10-01)

Pharmacokinetics, Efficacy and Safety of a Plasma-Derived VWF/FVIII Concentrate (Formulation V) in Pediatric Patients with von Willebrand Disease (SWIFTLY-VWD Study)
by: Auerswald G, et al.
Published: (2020-06-01)